Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing

Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing

IntroductionIn January 2023, our laboratory began performing serum myelin oligodendrocyte glycoprotein antibody (anti-MOG) titers by fixed cell-based assay (CBA). As a quality assurance (QA) assessment, we evaluated titer positive predictive value (PPV) as well as impact of sample collection timing...

Full description

Bibliographic Details
Main Authors: Adrian Budhram, Dalia L. Rotstein, Liju Yang, E. Ann Yeh
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Neurology
Subjects:
autoantibody
MOG
MOGAD
demyelinating disease
autoimmune neurology
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1380541/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1380541/full

Similar Items